Loading clinical trials...
Loading clinical trials...
Feasibility Performance Study Protocol for ABL90 FLEX PLUS HEM
This feasibility performance study evaluates the ABL90 FLEX PLUS HEM device for its analytical performance in a clinical setting. The study aims to evaluate the performance of the hemolysis detection feature.
The study is designed to assess the feasibility and performance of the ABL90 FLEX PLUS HEM device in a clinical environment. It will involve testing whole blood samples using the device and comparing results against established reference method. The primary focus is on validating the device's performance of the hemolysis detection function. The study will be conducted at one selected clinical site with trained personnel and will follow a predefined protocol to ensure consistency and reliability of data collection. The outcomes will inform future clinical studies aimed at supporting regulatory submissions and clinical adoption.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
Bispebjerg Hospital
Copenhagen, NV, Denmark
Start Date
August 4, 2025
Primary Completion Date
May 10, 2026
Completion Date
June 10, 2026
Last Updated
January 15, 2026
95
ESTIMATED participants
The purpose of this study is to investigate the performance of the hemolysis detection function on the ABL90 FLEX PLUS HEM using arterial or venous whole blood
DIAGNOSTIC_TEST
Lead Sponsor
Radiometer Medical ApS
Collaborators
NCT07466719
NCT06861816
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions